FRIDAY 8 NOVEMBER 2019
|13:00 – 14:30||REGISTRATIONS|
|14:30 – 15:30||ORAL PRESENTATIONS|
Chairs: Vrekoussis T., Pontikaki A.
|15.30 – 17:30||SESSION I: Hot Topics|
Chairs: Adonakis G., Xekouki P.
Pre-IVF+ thyroid function screening “why test, what to test and how to interpret
Pre IVF management of PCOS: How significant is the role of insulin sensitizers?
Life style changes to affect result in IVF?
Pre- IVF treatment of thin endometrium
|17:30 -18:00||COFFEE BREAK|
|18:00 – 19:30|
|SESSION II: Controversies|
Chairs: Messinis I., Kolibiannakis E.
Clinical utility of biomarkers in screening, diagnosis and prognosis of Endometriosis-Adenomyosis
Avoiding the LH surge: analogues vs. progesterone
How intense should we must stimulate the ovaries?
Individualized ovarian stimulation: Feasible or not?
|19:30 – 20:00|
|KEY NOTE LECTURE I|
Chair: Makrigiannakis A.
Stress in Utero
SATURDAY 9 NOVEMBER 2019
|08:00 – 09:00||ORAL PRESENTATIONS|
Chairs: Ziogos E., Michopoulou V.
|09:00 –10:30||SESSION III: Reproductive Surgery|
Chairs: Paschopoulos M., Feki A.
Treatment of uterine cavity defects: The do’s and don’ts
Pre IVF treatment of uterine fibroids: When does intervention become beneficial?
Is prevalence of infertility changing?
Anti a enolase antibody is a novel autoimmune biomarker for unexplained recurrent miscarriages
|10:30 -11:00||COFFEE BREAK|
|11:00 -12:30||SESSION IV: Can Early Pregnancy loss, be prevented|
Chairs: Makrigiannakis A., Toth B.
Should we transfer Mosaic Embryos in 2019?A role for pregnancy loss?
Is chronic endometritis a cause of recurrent pregnancy loss?
IVF as a treatment for recurrent pregnancy loss?
Miscarriage after IVF: What are the chances of eventual success?
|12:30–13:30||SATELLITE SYMPOSIUM I|
Chairs: Makrigiannakis A.Toppling established perceptions in the treatment of high responders
Makrakis E.Building treatment decisions upon the clinical evidence for the FSH/LH combinations
Sponsored by FERRING
|13:30 – 14:30||SATELLITE SYMPOSIUM II|
Chairs: Kalantaridou S., Giakoumakis I.
The impact of LH on reproductive outcomes
Optimize FSH & LH in IVF protocols
Sponsored by MERCK SERONO
|14:30 – 15:30||LIGHT LUNCH|
|15:30 – 17:00||SESSION V: Fertility Preservation|
Moderators: Rodolakis A., Vlachos N.
Potential malignant diseases of the endometrial cavity
Borderline and malignant ovarian disease and ovarian sparing surgery
Prepuberial fertility preservation
Fertility preservation in the future preventing loss of gametes
|17:00 -17:30||KEY NOTE LECTURE II|
Chairs: Loutradis D., Sallam H.
Poor Ovarian reserve: Do adjuvant therapies really work?
|17:30 – 18:00||COFFEE BREAK|
|18:00-19:30||SESSION VI: TBA|
Chairs: Veiga A., Zikopoulos K.
Diagnosis of uterine malformations with an impact on ART
ART children long reassurance?
Optimal cycle region for frozen embryo replacement
Is freeze all really better?
|19:30 – 20:00||KEY NOTE LECTURE III|
Chairs : Messinis I., Gianarolli L.
Should we use nuclear transfer for non mitochondrial diseases?
SUNDAY 10 NOVEMBER 2019
|08:00 – 09:00||ORAL PRESENTATIONS|
Chairs: Vrekoussis T., Rasidaki M.
|09:00 – 09:30||KEY NOTE LECTURE IV|
Chairs: Nikolettos N., Xekouki P.
Diabesity 21st Century disease
|09:30 – 10:00||KEY NOTE LECTURE V|
Chair: Zikopoulos K.
Epigenetics and bioenergetics in reproduction: role of micronutrients
|10:00 – 11:00||CONTRACEPTION|
Moderators: Messinis I., Deligeoroglou E.
Intrauterine contraception to whom examinations and test needed. How to deal with side effects
|11:00 – 11:30||COFFEE BREAK|
|11:30 – 12:00||KEY NOTE LECTURE VI|
Chair: Tarlatzis V.
Anthopogenic pressures in Reproductive Medicine
|12:00 – 12:30||KEY NOTE LECTURE VII|
Chair: Daponte A.
Possible associations between HPV infection, infertility and adverse pregnancy outcomes: An update
|12:30 – 14:00||SESSION VII : Maternal-Fetal-Reproduction|
Chairs: Athanasiadis A., Sifakis S.
Environmental pollutants and pregnancy
To whom to recommend NIPT testing?
Cervical shortening when to treat it?
Biomarkers for preterm birth?
|14:00 – 14:30||OPEN DISCUSSION – CONCLUSIONS|